Evaluation of Biofilm Formation and Antibiotic Resistance Pattern in Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains

被引:10
作者
Jomehzadeh, Nabi [1 ]
Ahmadi, Khadijeh [1 ]
Nasiri, Zahra [1 ]
机构
[1] Abadan Univ Med Sci, Sch Med, Dept Microbiol, Abadan, Iran
来源
BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL | 2022年 / 6卷 / 02期
关键词
Biofilm; escherichia coli; extended-spectrum beta-lactamase; urinary tract infection; NONTUBERCULOUS MYCOBACTERIA; MOLECULAR CHARACTERIZATION; RISK-FACTORS;
D O I
10.4103/bbrj.bbrj_270_21
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The increasing prevalence of multidrug-resistant (MDR) Escherichia coli strains, especially extended-spectrum beta-lactamase (ESBL)-producing strains, has become a global health concern. This study was aimed to determine the frequency of bla(CTX-M), bla(TEM), and bla(SHV) genes among E. coli isolates from urinary tract infection (UTI) and evaluate their antibiotic resistance pattern. Methods: Totally 98 E. coli isolates were recovered from urine samples of UTI-diagnosed patients. Antibiotic resistance and ESBL production were evaluated by disk diffusion and combined disk methods according to the Clinical Laboratory Standards Institute guidelines. The biofilm formation ability of isolates was assessed using the tube adherence method. ESBL-positive isolates were screened for bla(TEM), bla(CTX-M), and bla(SHV) genes by polymerase chain reaction. Results: Among the examined isolates, 25 (25.5%) were detected as ESBL producers and harbored at least one of the studied genes. The bla(CTX-M) was the predominant (44%) gene, followed by bla(TEM) (24%) and bla(SHV) (8%). The isolates revealed variable resistance levels to all antimicrobials, out of which 55.1% were conferred a high resistance rate to different antibiotic classes and considered MDR. Phenotypically, 42.85% of the isolates were biofilm formers, of which the majority (38%) formed moderate biofilms. Conclusions: This study showed that the ESBL-positive isolates were more resistant to some first-line antibiotics, and this highlights the necessity to control and monitor the prescribed antibiotics used for empirical treatment for UTI patients.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [31] Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria
    Ifeyinwa N. Nwafia
    Martin E. Ohanu
    Samuel O. Ebede
    Uchenna C. Ozumba
    Annals of Clinical Microbiology and Antimicrobials, 18
  • [32] Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections inWenzhou, China
    Bi, Wenzi
    Li, Bin
    Song, Jiangning
    Hong, Youliang
    Zhang, Xiaoxiao
    Liu, Haiyang
    Lu, Hong
    Zhou, Tieli
    Cao, Jianming
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (01) : 29 - 34
  • [33] Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain
    Drieux, Laurence
    Haenn, Sophie
    Moulin, Laurent
    Jarlier, Vincent
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2016, 5
  • [34] Multidrug resistance and transferability of blaCTX-M among extended-spectrum β-lactamase-producing enteric bacteria in biofilm
    Maheshwari, Meenu
    Ahmad, Iqbal
    Althubiani, Abdullah Safar
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 6 : 142 - 149
  • [35] Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Fresh Produce and Agricultural Environments in Korea
    Cha, Min-Hyeok
    Ryu, Jae-Gee
    Chi, Young-Min
    Woo, Gun-Jo
    JOURNAL OF FOOD PROTECTION, 2020, 83 (07) : 1115 - 1124
  • [36] Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
    Ha, Young Eun
    Kang, Cheol-In
    Cha, Min Kyeong
    Park, So Yeon
    Wi, Yu Mi
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (05) : 403 - 409
  • [37] Clinically Relevant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates From Food Animals in South Korea
    Song, Jihyun
    Oh, Sung-Suck
    Kim, Junghee
    Park, Sukyoung
    Shin, Jinwook
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [38] Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011
    Brolund, A.
    Edquist, P. J.
    Makitalo, B.
    Olsson-Liljequist, B.
    Soderblom, T.
    Wisell, K. Tegmark
    Giske, C. G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : O344 - O352
  • [39] Genomic characterisation of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli in Rabat, Morocco
    Ambroise, Jerome
    Benaissa, Elmostafa
    Irenge, Leonid Mwana Wa Bene
    Belouad, El Mehdi
    Bearzatto, Bertrand
    Durant, Jean-Francois
    Badir, Jamal
    Elouennass, Mostafa
    Gala, Jean-Luc
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 335 - 341
  • [40] Characterization of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients
    Halaji, Mehrdad
    Shahidi, Shahrzad
    Atapour, Abdolamir
    Ataei, Behrooz
    Feizi, Awat
    Havaei, Seyed Asghar
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 1429 - 1437